Mandate

Vinge advises Altor, the founders and the other sellers in connection with the divestment of a majority share in Eleda to Bain Capital

Vinge advises Altor Funds (“Altor”), the founders and the other sellers in connection with Bain Capital Private Equity (“Bain Capital”), a leading global private investment firm, acquiring a controlling stake in Eleda from Altor, which will reinvest a minority share. Eleda’s founders, Johan Halvardsson and Peter Condrup, and senior executives in Eleda will also reinvest a substantial share. Through the transaction, Altor, Eleda and Bain Capital establish a partnership for future expansion.

Headquartered in Stockholm and with approximately 3,000 employees, Eleda is a leading Nordic infrastructure development and services provider. The company is the market leader within several segments, many addressing the need of the green transition, including water and sewerage, power distribution, district heating, roads, data centres, railways, and electric vehicle charging stations. Eleda’s decentralised operating model allows its group companies to deliver the highest quality to their customers with the optimal mix of local presence and the resources of a larger organization.

The transaction is subject to regulatory approvals.

Vinge’s team consisted mainly of Christina Kokko, Johanna Wiberg, Carl Fredrik Wachtmeister, Ellen Flygt, Philip Moré, Jonatan Stentorp, Jonas Johansson, Nina Gransäter and Johan Gavelin (M&A), Louise Brorsson Salomon and Jolinn Uhlin (Banking and Finance), Martin Johansson and Hedvig Josefson (EU Regulatory), Emy Rydén, Emelie Schoning, Gabriella Balbo, Emma Emsjö, Christoffer Widström and Fanny Askelöf (Transaction Support Coordinators).

Read the client’s press release           

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025